European Congress of NeuroRehabilitation 2019

9–12 October 2019 • Budapest, Hungary

Congress details






Company Name: EVER Neuro Pharma GmbH
Street: Oberburgau 3
City, Zip Code : Unterach, 4866
Country : Austria
Website :

We are a globally successful pharmaceutical specialist. At our headquarters in Unterach, Austria, we are always on the search for new therapeutic solutions aimed at improving both the patients’ well-being and quality of life.

Cerebrolysin® is a biotechnologically manufactured original neuropeptide solution that stimulates neurotrophic regulation in the central nervous system. It is indicated for the treatment of stroke, traumatic brain injuries and cognitive impairment/dementia.

Tachyben is used for intravenous treatment of hypertensive emergencies. It is used to control lowering of blood pressure in hypertensive patients during and/or after surgery in cases of severe forms of hypertensive disease.



Established 1921 in Switzerland, Sintetica is a pharmaceutical company delivering injectable anaesthetics, analgesics and neuromodulation drugs to patients worldwide, through innovative science and excellence in development, production and marketing. Our sites are located in Switzerland, Germany, Austria, Italy and United Kingdom. The headquarter is in Mendrisio, Switzerland. The Swiss manufacturing sites of Mendrisio and Couvet have a production capability: 60 million glass ampoules, 10 million plastic ampoules, 5.5 infusion bags and 5 million vials. To manage the challenges, we are facing as an industry and to leverage the opportunities of the growth we have adopted two different business models. In Switzerland, Germany, Austria, UK and Ireland our national well experienced and professional teams directly promote and market our products. The international expansion is driven by a fast track partner selection and affiliation process in each and every target country of the world. A dynamic portfolio of selected branded medicines, developed to answer unmet clinical needs, is what the Global Division offers to our strategic international partners to build a sustainable and long lasting successful alliance. We are a multicultural company, our employees come from 28 different countries all over the world and they represent the biggest asset for us. That's why we believe in the great place to work culture that promotes creativity, informed risk-taking, an exciting environment and a good feeling in every day work.



Bioness solutions include implantable and external neuromodulation systems, robotics and software-based therapy programs providing functional and therapeutic benefits for individuals affected by pain, central nervous system disorders and orthopedic injuries. 

Bioness has a singular focus on aiding large, underserved customer groups with innovative, evidence-based clinical solutions. In addition to functional electrical stimulation devices and neurorehabilitation systems, the technology portfolio includes StimRouter, an implanted peripheral nerve stimulator indicated to treat chronic pain of peripheral nerve origin.

Bioness clinical solutions are distributed in over 25 countries worldwide.  

Learn more at | |